Literature DB >> 30440212

Liaison psychiatry in rural general practice.

Vincent Russell1, MacDara McCauley2, John MacMahon3, Sheila Casey3, Heather McCullagh3, Jillian Begley4.   

Abstract

The recent government health strategy document described the integration between primary and secondary care in Ireland as often poor and outlined plans to redress this deficit. In mental health care, the gradual shift away from institutions over the past four decades has resulted in the GP becoming the most frequent professional contact for people with mental disorders. However, access to specialist opinion is usually available only for the fraction of psychiatric presentations which are formally referred to the psychiatric service. On-site psychiatric liaison to primary care is commonly practised in other countries but not in Ireland. Research in the area suggests possible advantages for approaches which aim to enhance GPs' psychiatric skills while selectively encouraging referral of more serious disorders. This model has been adopted by GPs and psychiatrists in east Cavan and may be relevant to other similar settings, especially in the context of forthcoming changes in the organisation of primary care services.

Entities:  

Year:  2003        PMID: 30440212     DOI: 10.1017/S0790966700007667

Source DB:  PubMed          Journal:  Ir J Psychol Med        ISSN: 0790-9667


  2 in total

1.  Exploration of GP perspectives on deprescribing antidepressants: a qualitative study.

Authors:  Dervla Kelly; Justin Graffi; Maria Noonan; Philip Green; John McFarland; Peter Hayes; Liam Glynn
Journal:  BMJ Open       Date:  2021-04-05       Impact factor: 2.692

2.  Clinician perceptions of common mental disorders before and after implementation of a consultation-liaison psychiatry service: a longitudinal qualitative study in government-operated primary care settings in Penang, Malaysia.

Authors:  Vincent Russell; Ching Ee Loo; Aisling Walsh; Arokiamary Bharathy; Umadevi Vasudevan; Irene Looi; Susan M Smith
Journal:  BMJ Open       Date:  2021-06-30       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.